Identification | Back Directory | [Name]
MEDICARPIN | [CAS]
33983-40-3 | [Synonyms]
C01729 MEDICARPIN (+)-Demethylhomopterocarpin 3-HYDROXY-9-METHOXYPTEROCARPAN 9-methoxy-6a,11a-dihydro-6H-benzo[4,5]furo[3,2-c]chromen-3-ol (6aS,11aS)-6a,11a-Dihydro-9-methoxy-6H-benzofuro[3,2-c][1]benzopyran-3-ol [6aS,(+)]-6aβ,11aβ-Dihydro-9-methoxy-6H-benzofuro[3,2-c][1]benzopyran-3-ol | [Molecular Formula]
C16H14O4 | [MDL Number]
MFCD00161527 | [MOL File]
33983-40-3.mol | [Molecular Weight]
270.28 |
Hazard Information | Back Directory | [Uses]
Medicarpin can be used to inhibit IL-8 release via interactions with toll-like receptor 4 and lipopolysaccharide. It can also be used to treat COVID-19. | [Definition]
ChEBI: The (+)-enantiomer of medicarpin. |
|
Company Name: |
Carbosynth
|
Tel: |
+86 512 6260 5585 |
Website: |
www.carbosynth.com |
Company Name: |
ChromaDex
|
Tel: |
949 419 0288 |
Website: |
www.chromadex.com |
|